30 April 2024
For the fourth year running, media brand Medical Marketing and Media (MM+M) has listed Oxford PharmaGenesis in its Agency 100 report – the annual definitive ‘who’s who’ ranking of the healthcare sector’s top marketing firms in North America.
This month’s issue of Director magazine – the official publication of the UK Institute of Directors (IoD) – includes an interview with Dr Richard White, Commercial Director at Oxford PharmaGenesis. In the feature article, which profiles the IoD’s business information and advisory services, Richard describes how Oxford PharmaGenesis has used these services to address specific…
It’s been said that Professor Brian Cox has a brain the size of a planet, but you don’t need to look to the heavens to revel in numbers of astronomical proportions. Look inside his skull and you’d find 100 billion neurones plus another 100 billion supporting cells, which together form the blancmange that is the…
Oxford PharmaGenesis today celebrates winning the Queen’s Award for Enterprise. This honour, the UK’s highest accolade for business success, is awarded by the Queen on the advice of the Prime Minister, and is publicly announced on Her Majesty’s birthday. The global consultancy receives the award for Outstanding Achievement in International Trade, having more than doubled…
Oxford PharmaGenesis has recently held a fundraising event in Oxford and London, for Purple Day, an international initiative to increase awareness about epilepsy. To mark the day, staff wore purple to show their support for people living with this condition.
Oxford PharmaGenesis has recently joined OBN, the UK membership organization for innovative life science R&D companies in the golden triangle of Oxford, Cambridge and London – and beyond. Chris Winchester, Managing Director of Oxford PharmaGenesis, comments, “We are proud to be part of a support network for emerging life-science companies and offer our communications expertise.”
Real-world evidence (RWE) study publications and clinical trial data disclosure were two major topics of discussion at the 14th Annual Meeting of The International Publication Planning Association (TIPPA), with both keynote sessions being led by Oxford PharmaGenesis. The meeting, held in San Diego on 9–10 February 2015, was attended by an approximately even mix of…
